choline geranate
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 18, 2017 (NCT04498676)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04495920 | Early Phase 1 (Phase 1) | Jun 16, 2020 | Bio-Science Laboratories, CAGE Bio Inc. |
| NCT04498676 | N/A | Jan 18, 2017 | AMA Laboratories Inc., CAGE Bio Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CAGE Bio Inc. | For profit | 2 | 2 | 2 | 2017 |
| AMA Laboratories Inc. | For profit | 1 | 0 | 1 | 2017 |
| Bio-Science Laboratories | For profit | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1